FDA Inspection
Takeda Austria GmbHTakeda Austria GmbH – FDA Inspection, Jan 23, 2017
Record Details
This FDA Inspection record concerns Takeda Austria GmbH, with an inspection on January 23, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 616be53e-f0aa-46a5-b258-aa40ea12484c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002607
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Takeda Austria GmbH
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 11, 2025 | Not classified | Office of Inspections and Investigations | |
| February 14, 2025 | Not classified | Office of Inspections and Investigations | |
| November 12, 2024 | Not classified | Office of Inspections and Investigations | |
| November 9, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 28, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Takeda Austria GmbH
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.